Loading...
ADMA Biologics, Inc.
ADMA•NASDAQ
Healthcare
Biotechnology
$18.01
$0.70(4.04%)
ADMA Biologics, Inc. (ADMA) Financial Performance & Income Statement Overview
Review ADMA Biologics, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
65.15%
↑ 65.15%
Operating Income Growth
542.49%
↑ 542.49%
Net Income Growth
800.00%
↑ 800.00%
Operating Cash Flow Growth
1248.55%
↑ 1248.55%
Operating Margin
33.10%
↑ 33.10%
Gross Margin
52.55%
↑ 52.55%
Net Profit Margin
45.01%
↑ 45.01%
ROE
72.39%
↑ 72.39%
ROIC
33.26%
↑ 33.26%
ADMA Biologics, Inc. (ADMA) Income Statement & Financial Overview
Review ADMA Biologics, Inc.'s (ADMA) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $117.55M | $119.84M | $107.19M | $81.88M |
| Cost of Revenue | $54.22M | $60.18M | $49.88M | $42.96M |
| Gross Profit | $63.33M | $59.66M | $57.31M | $38.91M |
| Gross Profit Ratio | $0.54 | $0.50 | $0.53 | $0.48 |
| R&D Expenses | $391000.00 | $412000.00 | $560000.00 | $450000.00 |
| SG&A Expenses | $23.32M | $18.56M | $17.55M | $16.64M |
| Operating Expenses | $24.98M | $20.02M | $18.11M | $17.09M |
| Total Costs & Expenses | $77.92M | $80.20M | $67.99M | $60.05M |
| Interest Income | $598000.00 | $666000.00 | $449000.00 | $384000.00 |
| Interest Expense | $2.88M | $3.50M | $3.78M | $3.77M |
| Depreciation & Amortization | $1.94M | $1.94M | $2.05M | $2.11M |
| EBITDA | $39.54M | $42.19M | $41.68M | $23.93M |
| EBITDA Ratio | $0.34 | $0.35 | $0.39 | $0.29 |
| Operating Income | $38.32M | $39.64M | $39.20M | $21.82M |
| Operating Income Ratio | $0.33 | $0.33 | $0.37 | $0.27 |
| Other Income/Expenses (Net) | -$3.61M | -$2.89M | -$3.35M | -$3.42M |
| Income Before Tax | $34.71M | $36.75M | $35.85M | $18.40M |
| Income Before Tax Ratio | $0.30 | $0.31 | $0.33 | $0.22 |
| Income Tax Expense | -$77.18M | $840000.00 | $3.79M | $595000.00 |
| Net Income | $111.90M | $35.91M | $32.06M | $17.81M |
| Net Income Ratio | $0.95 | $0.30 | $0.30 | $0.22 |
| EPS | $0.47 | $0.15 | $0.14 | $0.08 |
| Diluted EPS | $0.46 | $0.15 | $0.13 | $0.08 |
| Weighted Avg Shares Outstanding | $236.43M | $234.57M | $232.42M | $228.87M |
| Weighted Avg Shares Outstanding (Diluted) | $245.90M | $244.80M | $242.17M | $236.41M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan